Don't understand why anyone would sell this for under 2 million MC - the EV of all of AGX's ventures is effectively valued by the market at a big fat ZERO
Some facts about AGX (from its last preso)
? ThromboView : For Blood Clot Diagnosis. Phase III ready. $38.5m capital has been expended on development and Phase 1 and 2 human trials. Currently AGX is looking for a partner and it has been looking since october last year
- DiagnostIQ: point of care rapid diagnostic platform can be partnered for multiple tests. AGX is partnered with Arrayjet Limited (Scotland) to develop microarray platform
- Directors hold 22% of shares
- Very low cash burn rate for a biotech in phase 3 (anyone have a figure on the costs for phase 3?)
-Top 20 shareholders hold 64.8% of shares
Extremely frustrated that I entered at 1.7 and then got sh*t out minutes later. Ideally would have gotten stopped out but fundamentals seem nice so I guess this is one of the failed-STT-becoming medium term holds LOL.
- Forums
- ASX - By Stock
- CT1
- cash flow
cash flow, page-21
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $109 | 54.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 7443517 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 6778957 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 7443517 | 0.002 |
29 | 22634991 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 6778957 | 8 |
0.004 | 4944996 | 5 |
0.005 | 2000000 | 1 |
0.007 | 2500000 | 2 |
0.008 | 1000001 | 1 |
Last trade - 15.52pm 18/10/2024 (20 minute delay) ? |
Featured News
CT1 (ASX) Chart |